Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | CETP | P11597 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.30 |
| ▸ | CCR2 | P41597 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2999697 | 0.87 | — | — | |
| SCHEMBL20658218 | 0.79 | ALDH1A1 (0.46) | FFAR3ALDH1A1SMN1; SMN2CETPP2RX7 | |
| SCHEMBL28260049 | 0.76 | ALDH1A1 (0.39) | FFAR3ALDH1A1SMN1; SMN2CETPP2RX7 | |
| SCHEMBL11922843 | 0.74 | FFAR3 (0.72) | FFAR3ALDH1A1SMN1; SMN2CETPCYP2C19 | |
| SCHEMBL13075808 | 0.74 | FFAR3 (0.72) | FFAR3ALDH1A1SMN1; SMN2CETPCYP2C19 | |
| SCHEMBL25213839 | 0.74 | FFAR3 (0.72) | FFAR3ALDH1A1SMN1; SMN2CETPCYP2C19 | |
| SCHEMBL14627497 | 0.74 | FFAR3 (0.72) | FFAR3ALDH1A1SMN1; SMN2CETPCYP2C19 | |
| SCHEMBL13341342 | 0.74 | FFAR3 (0.72) | FFAR3ALDH1A1SMN1; SMN2CETPCYP2C19 | |
| SCHEMBL19322861 | 0.74 | FFAR3 (0.72) | FFAR3ALDH1A1SMN1; SMN2CETPCYP2C19 | |
| SCHEMBL18449 | 0.74 | FFAR3 (0.72) | FFAR3ALDH1A1SMN1; SMN2CETPCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4001345-B1 | DEGRADABLE HYPERBRANCHED RESIN, PREPARATION METHOD THEREFOR, AND USE THEREOF | UNIV SOUTH CHINA TECH (CN) | 2026-04-01 | — | — | EP | claimed |
| CN-118348630-A | Polarizing plate and optical display device | 三星SDI株式会社 | 2024-07-16 | — | — | CN | claimed |
| CN-118348630-A | Polarizing plate and optical display device | 三星SDI株式会社 | 2024-07-16 | — | — | CN | disclosed |
| CN-114642735-A | Methods, compositions and systems for delivering therapeutic and diagnostic agents into cells | 菲泽尔克斯公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-107530436-B | Methods, compositions and systems for delivering therapeutic and diagnostic agents into cells | 菲泽尔克斯公司 | 2022-03-29 | — | — | CN | disclosed |
| EP-1314725-B1 | SULFONIUM SALT COMPOUND | WAKO PURE CHEM IND LTD (JP) | 2008-03-19 | — | — | EP | disclosed |
| US-6924323-B2 | Sulfonium salt compound | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2005-08-02 | — | — | US | disclosed |
| EP-1427763-A1 | METHOD FOR THE PRODUCTION OF POLYMERS AND COPOLYMERS FROM ACRYLIC COMPOUNDS | Röhm GmbH & Co. KG (DE) | 2004-06-16 | — | — | EP | disclosed |
| US-6723483-B1 | Sulfonium salt compounds | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2004-04-20 | — | — | US | disclosed |
| US-20040033434-A1 | Sulfonium salt compound | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2004-02-19 | — | — | US | disclosed |
| WO-2003048176-A1 | CATALYST FOR PRODUCING (CO)POLYMERS OF (METH)ACRYLIC COMPOUNDS | Röhm GmbH & Co. KG (DE) | 2003-06-12 | — | — | WO | disclosed |
| EP-1314725-A1 | SULFONIUM SALT COMPOUND | Wako Pure Chemical Industries, Ltd. (JP) | 2003-05-28 | — | — | EP | disclosed |
| WO-2003022897-A1 | METHOD FOR THE PRODUCTION OF POLYMERS AND COPOLYMERS FROM ACRYLIC COMPOUNDS | Röhm GmbH & Co. KG (DE) | 2003-03-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040033434-A1 | Sulfonium salt compound | SPIN1, RER1, SPIN2B | FFAR3 336/4885ALDH1A1 2370/4885SMN1; SMN2 838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.